BIIB vs MGPI · P/E 21, rev $9.89B vs rev $536.4M
Biogen Inc (BIIB) versus MGP Ingredients Inc (MGPI) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
MGP Ingredients Inc (MGPI) is a beverages - wineries & distilleries company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported MGPI revenue for 2025-12-31 was $536.4M. Net income was -$107.8M. Revenue was down 23.8% from 2024-12-31 to 2025-12-31. MGPI currently screens at market cap $336.8M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. MGPI currently screens at market cap $336.8M.
Not investment advice. Open the BIIB and MGPI stock pages for the full models.
Not investment advice.